Bibliografía del artículo
1. Gao X, Fan JG; Study Group of Liver and Metabolism, Chinese Society of Endocrinology. Diagnosis and management of non-alcoholic fatty liver disease and related metabolic disorders: consensus statement from the Study Group of Liver and Metabolism, Chinese Society of Endocrinology. J Diabetes 5(4):406-15, 2013.
2. Machado MV, Cortez-Pinto H. Non-alcoholic fatty liver disease: what the clinician needs to know. World J Gastroenterol 20(36):12956-80, 2014.
3. Hassan K, Bhalla V, El Regal ME, A-Kader HH. Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic. World J Gastroenterol 20(34):12082-101, 2014.
4. Levene AP, Goldin RD. The epidemiology, pathogenesis and histopathology of fatty liver disease. Histopathology 61(2):141-52, 2012.
5. Speliotes EK, Yerges-Armstrong LM, Wu J, Hernaez R, Kim LJ, Palmer CD, Gudnason V, Eiriksdottir G, Garcia ME, Launer LJ, Nalls MA, Clark JM, Mitchell BD, Shuldiner AR, Butler JL, Tomas M, Hoffmann U, Hwang SJ, Massaro JM, O' Donnell CJ, Sahani DV, Salomaa V, Schadt EE, Schwartz SM, Siscovick DS, Voight BF, Carr JJ, Feitosa MF, Harris TB, Fox CS, Smith AV, Kao WH, Hirschhorn JN, Borecki IB. Genomewide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 2011; 7:e1001324. DOI: 10.1371/journal.pgen.1001324.
6. Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH. Metabolic disturbances in non-alcoholic fatty liver disease. Clin Sci (Lond) 116(7):539-64, 2009.
7. Than NN, Newsome PN. A concise review of non-alcoholic fatty liver disease. Atherosclerosis 239(1):192-202, 2015.
8. Targher G, Bertolini L, Rodella S, Zoppini G, Zenari L, Falezza G. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 64(3):337-41, 2006.
9. Newton JL, Pairman J, Wilton K, Jones DE, Day C. Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease. Clin Auton Res 19(6):319-26, 2009.
10. D'Mello C, Swain MG. Liver-brain inflammation axis. Am J Physiol Gastrointest Liver Physiol 301(5):G749-61, 2011.
11. Yeniova AO, Küçükazman M, Ata N, Dal K, Kefeli A, Balyilit S, Aktal B, Alladiollu K, Akin KO, Ertugrul DT, Nazligül Y, Beyan E. High-sensitivity C-reactive protein is a strong predictor of non-alcoholic fatty liver disease. Hepatogastroenterology 61(130):422-5, 2014.
12. Riquelme A, Arrese M, Soza A, Morales A, Baudrand R, Pérez-Ayuso RM, González R, Alvarez M, Hernández V, García-Zattera MJ, Otarola F, Medina B, Rigotti A, Miquel JF, Marshall G, Nervi F. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int 29(1):82-8, 2009.
13. Rosenblat JD, Cha DS, Mansur RB, McIntyre RS. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry 53:23-34, 2014.
14. Dan AA, Kallman JB, Wheeler A, Younoszai Z, Collantes R, Bondini S, Gerber L, Younossi ZM. Health-related quality of life in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 26(6):815-20, 2007.
15. Chida Y, Sudo N, Kubo C. Does stress exacerbate liver diseases? J Gastroenterol Hepatol 21(1 Pt 2):202-8, 2006.
16. Cognitive deficits linked to nonalcoholic liver disease. American Neurological Association 2014 Annual Meeting. Abstract M1323. Presented October 13, 2014.
17. Alexander KS, Zakai NA, Gillett SR, Lidofsky SD, Callas PW, Unverzagt F, Wadley V, Judd SE, Cushman M. Abstract P341: Nonalcoholic Fatty Liver Disease and Risk of Incident Cognitive Impairment. Circulation 131:Suppl 1 AP341, Abstract, 2015.
18. Elwing JE, Lustman PJ, Wang HL, Clouse RE. Depression, anxiety, and nonalcoholic steatohepatitis. Psychosom Med 68(4):563-9, 2006.
19. Tomeno W, Kawashima K, Yoneda M, Saito S, Ogawa Y, Honda Y, Kessoku T, Imajo K, Mawatari H, Fujita K, Saito S, Hirayasu Y, Nakajima A. Nonalcoholic fatty liver disease comorbid with major depressive disorder: the pathological features and poor therapeutic efficacy. J Gastroenterol Hepatol, 2015 doi: 10.1111/jgh.12897.
20. Youssef NA, Abdelmalek MF, Binks M, Guy CD, Omenetti A, Smith AD, Diehl AM, Suzuki A. Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease. Liver Int 33(7):1062-70, 2013.
21. Hübscher SG Histological assessment of non-alcoholic fatty liver disease. Histopathology 49:450-465, 2006.
22. Surdea-Blaga T, Dumitralcu DL. Depression and anxiety in nonalcoholic steatohepatitis: is there any association? Rom J Intern Med 49(4):273-80, 2011.
23. Weinstein AA, Kallman Price J, Stepanova M, Poms LW, Fang Y, Moon J, Nader F, Younossi ZM. Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C. Psychosomatics 52(2):127-32, 2011.
24. Lee K, Otgonsuren M, Younoszai Z, Mir HM, Younossi ZM. Association of chronic liver disease with depression: a population-based study. Psychosomatics 54(1):52-9, 2013.
25. Voican CS, Corruble E, Naveau S, Perlemuter G. Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry 171(4):404, 2014.
26. Mello AF, Mello MF, Carpenter LL, Price LH. Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis. Rev Bras Psiquiatr 25(4):231-8, 2003.
27. Young JJ, Bruno D, Pomara N. A review of the relationship between proinflammatory cytokines and major depressive disorder. J Affect Disord 169:15-20, 2014.
28. Wang X, Michaelis EK. Selective neuronal vulnerability to oxidative stress in the brain. Front Ag Neurosci 2:12, 2010.
29. Rawdin BJ, Mellon SH, Dhabhar FS, Epel ES, Puterman E, Su Y, Burke HM, Reus VI, Rosser R, Hamilton SP, Nelson JC, Wolkowitz OM. Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun 31:143-52, 2013.